Oligonucleotide compositions and methods of use thereof
AssigneeWave Life Sciences Ltd.
InventorsMichael John Byrne, Vinod Vathipadiekal, Naoki Iwamoto, Chandra Vargeese, Lankai Guo
Life of this patent
Estimating the term…
Loading patent…
AssigneeWave Life Sciences Ltd.
InventorsMichael John Byrne, Vinod Vathipadiekal, Naoki Iwamoto, Chandra Vargeese, Lankai Guo
Estimating the term…
Among other things, the present disclosure provides USH2A oligonucleotides, and compositions and methods of use thereof, for preventing and/or treating various conditions, disorders or diseases. In some embodiments, provided USH2A oligonucleotides comprise nucleobase modifications, sugar modifications, internucleotidic linkage modifications and/or patterns thereof, and have improved properties, activities and/or selectivities. In some embodiments, the present disclosure provides USH2A oligonucleotides, compositions and methods for preventing and/or treating USH2A-related conditions, disorders or diseases, such as Usher Syndrome (e.g., Usher Syndrome Type 2A), atypical Usher syndrome, or nonsyndromic retinitis pigmentosa.
-26. (canceled)
A chirally controlled oligonucleotide composition comprising a plurality of oligonucleotides, wherein the oligonucleotides share:
(canceled)
(canceled)
-33. (canceled)
(canceled)
-44. (canceled)
Dependencies are inferred from the claim text.